|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$21.96 - $27.79
$2.2K - $2.78K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$13.6 - $17.88
$1.36K - $1.79K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$45.91 - $59.67
$4.59K - $5.97K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
600
|
$10.3 - $13.45
$6.18K - $8.07K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
9
|
$2.15 - $3.82
$19.3 - $34.4
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$1.97 - $2.67
$197 - $267
|
|
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
74
|
$52.88 - $57.05
$3.91K - $4.22K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
7,500
|
N/A
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
4,721
|
$17.06 - $25.59
$80.5K - $121K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
200
|
$12.95 - $18.24
$2.59K - $3.65K
|
|
Xeris Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 05, 2021
|
45
|
N/A
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$7.26 - $23.03
$726 - $2.3K
|
|
Nisun Intl Ent Dvpmt Gp CO LTD Com Cl A
|
Q3 2021
Filed on Nov 05, 2021
|
500
|
N/A
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
500
|
$5.8 - $8.02
$2.9K - $4.01K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
31
|
$15.75 - $23.5
$488 - $729
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
297
|
$29.04 - $29.86
$8.62K - $8.87K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
15
|
$41.82 - $51.87
$627 - $778
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
586
|
$6.98 - $8.47
$4.09K - $4.96K
|
|
|
|
Inmed Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 05, 2021
|
151
|
N/A
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
248
|
N/A
|
|
Minerva Neurosciences Inc
|
Q3 2021
Filed on Nov 05, 2021
|
1,000
|
N/A
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
2
|
$3779.0 - $4254.6
$7.56K - $8.51K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
9,000
|
$1.87 - $2.57
$16.8K - $23.1K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
36
|
$18.36 - $19.61
$661 - $706
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
40
|
$15.75 - $19.6
$630 - $784
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
11
|
$34.57 - $39.06
$380 - $430
|
|
Apex Technology Acquisition
|
Q3 2021
Filed on Nov 05, 2021
|
170
|
N/A
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
2,000
|
$2.21 - $2.89
$4.42K - $5.78K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
18
|
$17.37 - $27.92
$313 - $503
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
500
|
$13.18 - $19.83
$6.59K - $9.92K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
1,662
|
$25.61 - $32.81
$42.6K - $54.5K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
810
|
$6.28 - $9.79
$5.09K - $7.93K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
40
|
N/A
|
|
Fiduciary Claymore Engry Inf
|
Q3 2021
Filed on Nov 05, 2021
|
123
|
N/A
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
11
|
$32.64 - $38.64
$359 - $425
|
|
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
2,366
|
$9.09 - $9.43
$21.5K - $22.3K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
3,700
|
$5.01 - $6.8
$18.5K - $25.2K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
214
|
$5.9 - $7.44
$1.26K - $1.59K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
1,562
|
$3.17 - $4.61
$4.95K - $7.2K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
3,640
|
$11.31 - $13.47
$41.2K - $49K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
451
|
$27.23 - $27.63
$12.3K - $12.5K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
2,188
|
$17.16 - $30.45
$37.5K - $66.6K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
1,027
|
$15.91 - $20.08
$16.3K - $20.6K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
284
|
$18.06 - $20.91
$5.13K - $5.94K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
98
|
$46.1 - $63.75
$4.52K - $6.25K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
3,500
|
$9.31 - $16.52
$32.6K - $57.8K
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
10
|
$61.0 - $81.99
$610 - $820
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
113
|
$18.15 - $22.62
$2.05K - $2.56K
|
|
Vocera Communications Inc
|
Q3 2021
Filed on Nov 05, 2021
|
151
|
N/A
|
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
224
|
$31.43 - $33.2
$7.04K - $7.44K
|
|